908
Participants
Start Date
October 27, 2023
Primary Completion Date
July 6, 2032
Study Completion Date
July 6, 2032
Diroximel Fumarate
Administered as specified in the treatment arm.
Avonex
Administered as specified in the treatment arm.
Tysabri
Administered as specified in the treatment arm.
Dimethyl Fumarate
Administered as specified in the treatment arm.
RECRUITING
Inselspital, Bern
RECRUITING
Austin Hospital, Heidelberg
RECRUITING
IQVIA US Office, Durham
RECRUITING
Hospital Universitario Ramon y Cajal, Madrid
RECRUITING
Katholisches Klinikum Bochum, Bochum
RECRUITING
University of Colorado Anschutz Medical Campus, Aurora
RECRUITING
St Vincent's University Hospital, Dublin
Lead Sponsor
Biogen
INDUSTRY